Share on Facebook
Share on Twitter
Share on LinkedIn

Pfizer’s Consumer Healthcare is pulling tens of thousands of bottles of one of its adult Robitussin products in the U.S. due to a labeling issue. It comes just weeks after a different kind of manufacturing snafu led to the recall of its children’s Advil products in Canada.

According to the most recent FDA Enforcement Report, Pfizer ($PFE) is voluntarily recalling 63,636 bottles of Adult Robitussin PEAK COLD Cough & Chest Congestion DM Liquid in 8-oz. bottles. The FDA report didn’t give specifics, but according to a notice posted on the website of supermarket chain Wegmans, some of the PEAK COLD meds had been mislabeled as Adult Robitussin Maximum Strength Nighttime Cough DM. The recall began in February but was just posted this week by the FDA.

 Read more